Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial.

Bowden CL, Vieta E, Ice KS, Schwartz JH, Wang PP, Versavel M.

J Clin Psychiatry. 2010 Feb;71(2):130-7. doi: 10.4088/JCP.09m05482yel. Epub 2010 Jan 26.

PMID:
20122373
2.

A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently.

Macfadden W, Alphs L, Haskins JT, Turner N, Turkoz I, Bossie C, Kujawa M, Mahmoud R.

Bipolar Disord. 2009 Dec;11(8):827-39. doi: 10.1111/j.1399-5618.2009.00761.x.

PMID:
19922552
3.

Prevalence and burden of general medical conditions among adults with bipolar I disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Perron BE, Howard MO, Nienhuis JK, Bauer MS, Woodward AT, Kilbourne AM.

J Clin Psychiatry. 2009 Oct;70(10):1407-15. doi: 10.4088/JCP.08m04586yel.

4.

Olanzapine in the long-term treatment of bipolar disorder: a systematic review and meta-analysis.

Cipriani A, Rendell J, Geddes JR.

J Psychopharmacol. 2010 Dec;24(12):1729-38. doi: 10.1177/0269881109106900. Epub 2009 Oct 14. Review.

PMID:
19828571
5.

The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments.

Ng F, Mammen OK, Wilting I, Sachs GS, Ferrier IN, Cassidy F, Beaulieu S, Yatham LN, Berk M; International Society for Bipolar Disorders.

Bipolar Disord. 2009 Sep;11(6):559-95. doi: 10.1111/j.1399-5618.2009.00737.x.

PMID:
19689501
6.

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.

Yatham LN, Kennedy SH, Schaffer A, Parikh SV, Beaulieu S, O'Donovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Young AH, Alda M, Milev R, Vieta E, Calabrese JR, Berk M, Ha K, Kapczinski F.

Bipolar Disord. 2009 May;11(3):225-55. doi: 10.1111/j.1399-5618.2009.00672.x.

PMID:
19419382
7.

Clinical practice recommendations for bipolar disorder.

Malhi GS, Adams D, Lampe L, Paton M, O'Connor N, Newton LA, Walter G, Taylor A, Porter R, Mulder RT, Berk M; Northern Sydney Central Coast Mental Health Drug & Alcohol; NSW Health Clinical Redesign Program; CADE Clinic, University of Sydney.

Acta Psychiatr Scand Suppl. 2009;(439):27-46. doi: 10.1111/j.1600-0447.2009.01383.x.

PMID:
19356155
8.

Teratogenesis associated with antibipolar agents.

Nguyen HT, Sharma V, McIntyre RS.

Adv Ther. 2009 Mar;26(3):281-94. doi: 10.1007/s12325-009-0011-z. Epub 2009 Mar 28. Review.

PMID:
19330496
9.

Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology.

Goodwin GM; Consensus Group of the British Association for Psychopharmacology.

J Psychopharmacol. 2009 Jun;23(4):346-88. doi: 10.1177/0269881109102919. Epub 2009 Mar 27.

PMID:
19329543
10.
11.

Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127).

Suppes T, Vieta E, Liu S, Brecher M, Paulsson B; Trial 127 Investigators.

Am J Psychiatry. 2009 Apr;166(4):476-88. doi: 10.1176/appi.ajp.2008.08020189. Epub 2009 Mar 16.

PMID:
19289454
12.

Premature mortality from general medical illnesses among persons with bipolar disorder: a review.

Roshanaei-Moghaddam B, Katon W.

Psychiatr Serv. 2009 Feb;60(2):147-56. doi: 10.1176/appi.ps.60.2.147. Review.

PMID:
19176408
13.

Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials.

Geddes JR, Calabrese JR, Goodwin GM.

Br J Psychiatry. 2009 Jan;194(1):4-9. doi: 10.1192/bjp.bp.107.048504. Review.

14.

Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).

Vieta E, Suppes T, Eggens I, Persson I, Paulsson B, Brecher M.

J Affect Disord. 2008 Aug;109(3):251-63. doi: 10.1016/j.jad.2008.06.001. Epub 2008 Jun 24.

PMID:
18579216
15.

Comorbid anxiety in bipolar disorder alters treatment and prognosis.

El-Mallakh RS, Hollifield M.

Psychiatr Q. 2008 Jun;79(2):139-50. doi: 10.1007/s11126-008-9071-5. Epub 2008 May 20. Review.

PMID:
18491230
16.

Diagnostic guidelines for bipolar depression: a probabilistic approach.

Mitchell PB, Goodwin GM, Johnson GF, Hirschfeld RM.

Bipolar Disord. 2008 Feb;10(1 Pt 2):144-52. doi: 10.1111/j.1399-5618.2007.00559.x. Review.

PMID:
18199233
17.

Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo.

Keck PE Jr, Calabrese JR, McIntyre RS, McQuade RD, Carson WH, Eudicone JM, Carlson BX, Marcus RN, Sanchez R; Aripiprazole Study Group.

J Clin Psychiatry. 2007 Oct;68(10):1480-91.

PMID:
17960961
18.

Treatment of bipolar disorder during pregnancy.

Cohen LS.

J Clin Psychiatry. 2007;68 Suppl 9:4-9. Review.

19.

Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial.

Miklowitz DJ, Otto MW, Frank E, Reilly-Harrington NA, Kogan JN, Sachs GS, Thase ME, Calabrese JR, Marangell LB, Ostacher MJ, Patel J, Thomas MR, Araga M, Gonzalez JM, Wisniewski SR.

Am J Psychiatry. 2007 Sep;164(9):1340-7.

20.

Epidemiology, diagnosis and management of mixed mania.

González-Pinto A, Aldama A, Mosquera F, González Gómez C.

CNS Drugs. 2007;21(8):611-26. Review.

PMID:
17630815

Supplemental Content

Support Center